Phillip Brian Smith: Clinical Trials

8 trials sponsored by Phillip Brian Smith, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 withdrawn. 8 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 18Completed 7, Withdrawn 1

Follow Phillip Brian Smith: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PK Study With Pantoprazole in Obese Children and Adolescents
Pantoprazole - Gastroesophageal Reflux Disease
Phase 1CompletedPhillip Brian Smith412014-06-042019-09-17
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
cefazolin - Sepsis, Prematurity
Phase 1CompletedPhillip Brian Smith92013-07-012018-09-04
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Clindamycin - Bacterial Infections, Obesity
Phase 1CompletedPhillip Brian Smith222013-06-012016-11-29
Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)
Antibiotic - Systemic Infection
Phase 1CompletedPhillip Brian Smith632013-01-012023-07-27
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
Acyclovir - Herpes Simplex Virus, Neonatal Sepsis
Phase 1CompletedPhillip Brian Smith322011-09-012019-01-08
Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants
Ticarcillin-clavulanic acid - Sepsis
Phase 1WithdrawnPhillip Brian Smith2010-09-012012-11-14
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
piperacillin-tazobactam - Sepsis
Phase 1CompletedPhillip Brian Smith322009-10-012018-10-03
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
voriconazole - Graft Versus Host Disease, Stem Cell Transplantation
Phase 1CompletedPhillip Brian Smith52008-12-012018-09-04

Conditions studied

Sepsis (4)  ·  Obesity (2)  ·  Premature Birth (2)  ·  Bacterial Infections (1)  ·  Gastroesophageal Reflux (1)  ·  Graft vs Host Disease (1)  ·  Herpes Simplex (1)  ·  Neonatal Sepsis (1)  ·  Toxemia (1)

Interventions

Acyclovir (1)  ·  Anti-Bacterial Agents (1)  ·  Cefazolin (1)  ·  Clindamycin (1)  ·  Pantoprazole (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Solutions (1)  ·  Voriconazole (1)  ·  clindamycin palmitate (1)  ·  clindamycin phosphate (1)  ·  ticarcillin-clavulanic acid (1)

Countries

United States (7)  ·  Brazil (1)

Top investigators

Kevin Watt, MD (1)  ·  Michael J Smith, MD (1)  ·  P Brian Smith, MD (1)  ·  P. Brian Smith, MD, MHS, MPH (1)  ·  Philip B Smith, MD (1)  ·  Phillip B Smith, M.D. (1)  ·  Phillip B Smith, MD (1)  ·  Phillip B. Smith, MD (1)

Results publications

PMID 18846389, PMID 22569355, PMID 24949994, PMID 26926644, PMID 28137820, PMID 29389444, PMID 30710387, PMID 30910891, PMID 8517703

NIH funding

K23HD060040 (1)